ATE82291T1 - Clavamderivate, herstellung und zwischenprodukte. - Google Patents

Clavamderivate, herstellung und zwischenprodukte.

Info

Publication number
ATE82291T1
ATE82291T1 AT86306564T AT86306564T ATE82291T1 AT E82291 T1 ATE82291 T1 AT E82291T1 AT 86306564 T AT86306564 T AT 86306564T AT 86306564 T AT86306564 T AT 86306564T AT E82291 T1 ATE82291 T1 AT E82291T1
Authority
AT
Austria
Prior art keywords
manufacture
intermediate products
clavam
derivatives
clavam derivatives
Prior art date
Application number
AT86306564T
Other languages
English (en)
Inventor
Stephen William Elson
Stefan Roland Woroniecki
Keith Howard Baggaley
Original Assignee
Beecham Group Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group Plc filed Critical Beecham Group Plc
Application granted granted Critical
Publication of ATE82291T1 publication Critical patent/ATE82291T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • G—PHYSICS
    • G02—OPTICS
    • G02B—OPTICAL ELEMENTS, SYSTEMS OR APPARATUS
    • G02B1/00—Optical elements characterised by the material of which they are made; Optical coatings for optical elements
    • G02B1/10—Optical coatings produced by application to, or surface treatment of, optical elements
    • G02B1/14—Protective coatings, e.g. hard coatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D503/00—Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/188—Heterocyclic compound containing in the condensed system at least one hetero ring having nitrogen atoms and oxygen atoms as the only ring heteroatoms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465—Streptomyces

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrrole Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
AT86306564T 1985-08-29 1986-08-26 Clavamderivate, herstellung und zwischenprodukte. ATE82291T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB858521516A GB8521516D0 (en) 1985-08-29 1985-08-29 Compounds
EP86306564A EP0213914B1 (de) 1985-08-29 1986-08-26 Clavamderivate, Herstellung und Zwischenprodukte

Publications (1)

Publication Number Publication Date
ATE82291T1 true ATE82291T1 (de) 1992-11-15

Family

ID=10584437

Family Applications (1)

Application Number Title Priority Date Filing Date
AT86306564T ATE82291T1 (de) 1985-08-29 1986-08-26 Clavamderivate, herstellung und zwischenprodukte.

Country Status (11)

Country Link
US (2) US4795809A (de)
EP (1) EP0213914B1 (de)
JP (4) JP2530825B2 (de)
AT (1) ATE82291T1 (de)
CA (1) CA1338143C (de)
DE (1) DE3687100T2 (de)
ES (1) ES2001410A6 (de)
GB (1) GB8521516D0 (de)
GR (1) GR862214B (de)
HK (1) HK26596A (de)
PT (1) PT83267B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8813055D0 (en) * 1988-06-02 1988-07-06 Beecham Group Plc Novel substance
JP3730263B2 (ja) * 1992-05-27 2005-12-21 ケーエルエー・インストルメンツ・コーポレーション 荷電粒子ビームを用いた自動基板検査の装置及び方法
WO1994012654A1 (en) * 1992-12-02 1994-06-09 Smithkline Beecham Plc Process for preparing clavulanic acid
SI9400107A (en) 1994-03-02 1995-10-31 Lek Tovarna Farmacevtskih New process of the isolation of clavulanic acid and its pharmaceutical salts from fermented broth of streptomyces sp.p 6621 ferm p 2804.
SI9500074A (en) * 1995-03-10 1996-10-31 Lek Tovarna Farmacevtskih Process for preparation of alkani salts of clavulanic acid.
GB9515809D0 (en) * 1995-08-02 1995-10-04 Smithkline Beecham Plc Process
GB9702218D0 (en) * 1997-02-04 1997-03-26 Smithkline Beecham Plc Novel product

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3862008A (en) * 1973-12-03 1975-01-21 Lilly Co Eli Process for deacetoxycephalosporin c.
US4110165A (en) * 1974-04-20 1978-08-29 Beecham Group Limited Process for the production of clavulanic acid
GB1563103A (en) * 1975-10-13 1980-03-19 Beecham Group Ltd Process for the preparation of clavulanic acid
US4078067A (en) * 1976-04-12 1978-03-07 Merck & Co., Inc. 3-(.beta.-Aminoethylidene)-7-oxo-4-oxaazabicyclo[3.2.0]heptane-2-carboxylic acid and derivatives thereof
GB1585124A (en) * 1976-06-04 1981-02-25 Glaxo Lab Ltd Clavulanic acid derivatives
AT363181B (de) * 1976-10-25 1981-07-10 Glaxo Lab Ltd Verfahren zur herstellung von neuen clavulansaeurederivaten
GB1603208A (en) * 1977-04-27 1981-11-18 Beecham Group Ltd Aminodeoxyclavulanic acid and acyl derivatives threreof
DK330880A (da) * 1979-08-03 1981-02-04 Beecham Group Ltd Fremgangsmaade til fremstilling af clavulansyrederivater
JPS5835677B2 (ja) * 1982-08-05 1983-08-04 武田薬品工業株式会社 新菌種ストレプトミセス・カツラハマヌス

Also Published As

Publication number Publication date
JP2648472B2 (ja) 1997-08-27
US4795809A (en) 1989-01-03
DE3687100D1 (de) 1992-12-17
HK26596A (en) 1996-02-16
JPH08242874A (ja) 1996-09-24
GR862214B (en) 1986-12-31
PT83267B (pt) 1988-08-17
EP0213914A2 (de) 1987-03-11
JPH08266274A (ja) 1996-10-15
DE3687100T2 (de) 1993-04-15
JP2698062B2 (ja) 1998-01-19
ES2001410A6 (es) 1988-05-16
EP0213914A3 (en) 1988-07-27
PT83267A (en) 1986-09-01
JPH08259530A (ja) 1996-10-08
JP2604571B2 (ja) 1997-04-30
US5130241A (en) 1992-07-14
EP0213914B1 (de) 1992-11-11
JPS6259281A (ja) 1987-03-14
GB8521516D0 (en) 1985-10-02
JP2530825B2 (ja) 1996-09-04
CA1338143C (en) 1996-03-12

Similar Documents

Publication Publication Date Title
ES8704161A1 (es) Un procedimiento para preparar dihidroquinoleinas antibacterianas.
HUT45984A (en) Process for production of quinoline-derivatives and of their medically acceptable acid-additioned salts
FI861506A (fi) Foerfarande foer framstaellning av 1,2-ditiolan-3-pentansyra (tioktsyra).
ATE82291T1 (de) Clavamderivate, herstellung und zwischenprodukte.
MY101618A (en) Intermediates for the production of epipodophyloxin and related compounds and processes for the preparation and use thereof
HUT40614A (en) Process for production of derivatives of amin-akryl-acid
DE3267188D1 (en) Hydroxybenzylamino-aryl compounds, process for preparing and pharmaceutical compositions containing the same
FI864970A (fi) Nya kristallina salter av aryloxi-propanolaminer, foerfarande foer deras framstaellning och deras anvaendning.
ES8201169A1 (es) Un procedimiento para la preparacion de derivados de quina- zolina
BR8207274A (pt) Processo para preparacao de um 2-exo-hidroxi-7-octabiciclo-(2,2,1)-heptano, e composto.
PT76693A (en) (-)-15-deoxyspergualin a process for the preparation of the same an intermediate of the same and its use as medicament
PL268034A1 (en) The method of manufacture of new 7-phenylglycil-1-carbo-destiacephalosphorines
FI860074A (fi) Oktahydroindolizinfoereningar anvaendbara som smaertstillande medel.
ATE60779T1 (de) N-glykolylneuraminsaeurederivat.
AU575964B2 (en) Pineapple ketone carbonate derivatives
AU6089686A (en) 1-alkyl ergolinylthiourea derivatives, process for the preparation thereof, as well as their use as medicinal agents
IE862533L (en) Bicyclic catechol derivatives
DE3572965D1 (en) Process for the production of optically active quinone derivatives
ES2130392T3 (es) Procedimiento para la preparacion de acido clavulanico.
DE69204766D1 (de) Verfahren zur Herstellung von Bicyclo(3.2.0)hept-2-en-7-onen.
DE2966347D1 (en) Clavulanic acid derivatives and process for their preparation
DE3263316D1 (en) New compound having analgesic, antiinflammatory and mucoregulating activities, process for its production and relative pharmaceutical compositions
ES2194871T3 (es) Deshidrogenasa del acido clavulanico, preparacion y uso para la produccion de acido clavulanico.
FR2446818A1 (fr) Tetrahydro-2h-benzo(c)pyrroles utiles comme intermediaires
SU1626642A1 (ru) 3-Алкил-4-метил-2,9-диоксо-3,8-диазабицикло[4,3,0]нона-1(6), 4-диенилийперхлораты, обладающие противовоспалительным действием